Association between blood eosinophil count with asthma hospital readmissions

Published:March 04, 2018DOI:


      • The blood eosinophil count (BEC) could have some impact on asthma.
      • The relationship between BEC and asthma prognosis is still under debate.
      • The effect doesn't seem to be the same in all populations.
      • In our population less BEC is related to more exacerbations.



      The presence of eosinophils in asthma inflammation is a relevant factor in the pathophysiology of the disease, however the relationship between the blood eosinophil count (BEC) with asthma severity and prognosis is still under debate.
      The aim of this work is to analyze the relationship between the BEC levels and hospital readmissions in patients with asthma.

      Material and methods

      A review was retrospectively carried out on all admissions of patients over 18 years old due to exacerbation of asthma occurring in our hospital between the years 2000 and 2010. The personal characteristics and the asthma personal history of each patient were recorded. The BEC was determined from the first blood sample taken from the patient after their arrival at the hospital. Hospital early, late and frequent readmissions were analyzed using 4 cut-off points; less than 150 eosinophils/μL vs ≥150/μL, less than 200 vs 200 /μL, less than 300 vs ≥300/μL, and less than 400 vs ≥400/μL.


      We have included 1316 patients, 70% of whom are women, as well as a mean age of 60 years, and a mean FEV1 of 73.5% of the reference value. The mean eosinophil blood count was 201.7 cells/μL. A BEC ≥300 cells/μL showed a reduction of risk of late readmission of 42%, a BEC ≥400 cells/μL showed a reduction in late readmission risk of 41% and decrease in frequent late readmission of 63%.


      Our study appears to support that an elevated BEC is associated with a lower incidence of asthma hospital readmissions.

      Graphical abstract


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Denlinger L.C.
        • Phillips B.R.
        • Ramratnam S.
        • et al.
        Inflammatory and comorbid features of patients with severe asthma and frequent exacerbations.
        Am J Respir Crit Care Med. 2017; 195: 302-313
        • Muñoz X.
        • Bustamante V.
        • Lopez-Campos J.L.
        • et al.
        Usefulness of noninvasive methods for the study of bronchial inflammation in the control of patients with asthma.
        Int Arch Allergy Immunol. 2015; 166: 1-12
        • Albers F.C.
        • Müllerová H.
        • Gunsoy N.B.
        • et al.
        Biologic treatment eligibility for real-world patients with severe asthma: The IDEAL study.
        J Asthma. 2017; : 1-9
        • Gauthier M.
        • Ray A.
        • Wenzel S.E.
        Evolving concepts of asthma.
        Am J Respir Crit Care Med. 2015; 192: 660-668
        • Wenzel S.E.
        • Schwartz L.B.
        • Langmack E.L.
        • et al.
        Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics.
        Am J Respir Crit Care Med. 1999; 160: 1001-1008
        • Amelink M.
        • de Groot J.C.
        • de Nijs S.B.
        • et al.
        Severe adult-onset asthma: a distinct phenotype.
        J Allergy Clin Immunol. 2013; 132: 336-341
        • Silkoff P.E.
        • Strambu I.
        • Laviolette M.
        • et al.
        Asthma characteristics and biomarkers from the airways disease Endotyping for personalized therapeutics (ADEPT) longitudinal profiling study.
        Respir Res. 2015; 16: 142
        • Schleich F.N.
        • Chevremont A.
        • Paulus V.
        • et al.
        Importance of concomitant local and systemic eosinophilia in uncontrolled asthma.
        Eur Respir J. 2014 Jul; 44: 97-108
        • Inoue H.
        • Ito I.
        • Niimi A.
        • et al.
        CT-assessed large airway involvement and lung function decline in eosinophilic asthma: the association between induced sputum eosinophil differential counts and airway remodeling.
        J Asthma. 2016; 53: 914-921
        • Price D.B.
        • Rigazio A.
        • Campbell J.D.
        • et al.
        Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study.
        Lancet Respir Med. 2015; 3: 849-858
        • Zeiger R.S.
        • Schatz M.
        • Li Q.
        • et al.
        High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma.
        J Allergy Clin Immunol Pract. 2014; 2: 741-750
        • Pola-Bibian B.
        • Dominguez-Ortega J.
        • Vilà-Nadal G.
        • et al.
        Asthma exacerbations in a tertiary hospital: clinical features, triggers, and risk factors for hospitalization.
        J Investig Allergol Clin Immunol. 2016; 0
        • Katz L.E.
        • Gleich G.J.
        • Hartley B.F.
        • et al.
        Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma.
        Ann Am Thorac Soc. 2014; 11: 531-536
        • Nair P.
        What is an “eosinophilic phenotype” of asthma?.
        J Allergy Clin Immunol. 2013; 132: 81-83
        • Domínguez-Ortega J.
        • Phillips-Anglés E.
        • Barranco P.
        • et al.
        Cost-effectiveness of asthma therapy: a comprehensive review.
        J Asthma. 2015; 52: 529-537
        • Ivanova J.I.
        • Bergman R.
        • Birnbaum H.G.
        • Colice G.L.
        • Silverman R.A.
        • McLaurin K.
        Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma.
        J Allergy Clin Immunol. 2012; 129: 1229-1235
        • Gonzalez Barcala F.J.
        • La Fuente-Cid R.D.
        • Alvarez-Gil R.
        • Tafalla M.
        • Nuevo J.
        • Caamaño-Isorna F.
        Factors associated with a higher prevalence of work disability among asthmatic patients.
        J Asthma. 2011; 48: 194-199
        • Gonzalez-Barcala F.J.
        • Aboal J.
        • Carreira J.M.
        • et al.
        Trends of asthma mortality in Galicia from 1993 to 2007.
        J Asthma. 2012 Dec; 49: 1016-1020
        • Gonzalez-Barcala F.J.
        • Aboal J.
        • Valdes L.
        • et al.
        Trends in adult asthma hospitalization: gender-age effect.
        Multidiscip Respir Med. 2011 Apr 30; 6: 82-86
        • Buyantseva L.V.
        • Brooks J.
        • Rossi M.
        • Lehman E.
        • Craig T.J.
        Risk factors associated with 30-day asthma readmissions.
        J Asthma. 2016; 53: 684-690
        • Ashton C.M.
        • Kuykendall D.H.
        • Johnson M.L.
        • Wray N.P.
        • Wu L.
        The association between the quality of inpatient care and early readmission.
        Ann Intern Med. 1995; 122: 415-421
        • Moran J.
        • Colbert C.Y.
        • Song J.
        • et al.
        Residents examine factors associated with 30-day, same-cause hospital readmissions on an internal medicine service.
        Am J Med Qual. 2013; 28: 492-501
        • Charlson M.E.
        • Pompei P.
        • Ales K.L.
        • MacKenzie C.R.
        A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.
        J Chronic Dis. 1987; 40: 373-383
        • A Malinovschi
        • Fonseca J.A.
        • Jacinto T.
        • et al.
        Exhaled nitric oxide levels and blood eosinophil counts independently associate with wheeze and asthma events in National Health and nutrition examination survey subjects.
        J Allergy Clin Immunol. 2013; 132: 821-827
        • Tran T.N.
        • Khatry D.B.
        • Ke X.
        • et al.
        High blood eosinophil count is associated with more frequent asthma attacks in asthma patients.
        Ann Allergy Asthma Immunol. 2014; 113 (Westerhof et al (erj 2015:688)): 19-24
        • Zhang X.Y.
        • Simpson J.L.
        • Powell H.
        • et al.
        Full blood count parameters for the detection of asthma inflammatory phenotypes.
        Clin Exp Allergy. 2014; 44: 1137-1145
        • McGrath K.W.
        • Icitovic N.
        • Boushey H.A.
        • et al.
        A large subgroup of mild-to-moderate asthma is persistently noneosinophilic.
        Am J Respir Crit Care Med. 2012; 185: 612-619
        • Hastie A.T.
        • Moore W.C.
        • Li H.
        • et al.
        Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects.
        J Allergy Clin Immunol. 2013; 132: 72-80
        • SL Spector
        • Tan R.A.
        Is a single blood eosinophil count a reliable marker for “eosinophilic asthma?”.
        J Asthma. 2012; 49: 807-810
        • Hancox R.J.
        • Cowan D.C.
        • Aldridge R.E.
        • et al.
        Asthma phenotypes: consistency of classification using induced sputum.
        Respirology. 2012; 17: 461-466
        • RM Eggo
        • JG Scott
        • AP Galvani
        • et al.
        Respiratory virus transmission dynamics determine timing of asthma exacerbation peaks: evidence from a population-level model.
        Proc Natl Acad Sci U S A. 2016; 113: 2194-2199
        • Zhu J.
        • Message S.D.
        • Qiu Y.
        • et al.
        Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma.
        Chest. 2014; 145: 1219-1229
        • Canadian Institute for Health Information
        CIHI data quality study of the 2005e2006 discharge abstract database. Ottawa, Ontario.
        ([Accessed 8 Aug 17])